MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0013613
Cytocure Medicare Private Limited
Cytocure Medicare Private Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹55.94 Cr
▲ 11% YoY
Net loss · FY 2025
₹2.65 Cr
Net margin -4.7%
EBITDA · FY 2025
₹2.13 Cr
EBITDA margin 3.8%
Authorised capital
₹5.2 Cr
Registered with MCA
Paid-up capital
₹5.14 Cr
Issued & subscribed
Open charges
₹12.96 Cr
Secured borrowings
Company age
7 yrs
Est. 2019
Employees · EPFO
28
Provident fund records
About Cytocure Medicare Private Limited
Data last updated:
Cytocure Medicare Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Spj Onco Care Private Limited. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 07 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85300MH2019PTC319108. Its GSTIN is 27AAHCC9435D1ZM (Maharashtra).
The company has an authorised share capital of ₹5.2 Cr and a paid-up capital of ₹5.14 Cr. It is led by directors Sanket Sharad Mehta and Jageshwar Prasad Pandey.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹55.94 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net loss of ₹2.65 Cr (net margin -4.7%) and EBITDA of ₹2.13 Cr (EBITDA margin 3.8%). Revenue has grown at a compounded annual rate (CAGR) of 46% over three years and 310% over five years.
The company has about 28 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: SSO Hospital. As per MCA filings, the company has open charges of ₹12.96 Cr on record.
Cytocure Medicare Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0013613).
Company details
CIN U85300MH2019PTC319108
Registration Number 319108
Incorporation Date 07 January 2019
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Spj Onco Care Private Limited
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0013613
Recognitions & Rankings of Cytocure Medicare
Contact details
Cytocure Medicare Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address6th Floor 601 & 602 Plot No.501 F3 Silver Point Lbs Marg New Maneklal Estate Ghatkopar, West, Mumbai, Maharashtra, India – 400086
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Cytocure Medicare Private Limited, buy the company report.
Comprehensive company report
Cytocure Medicare Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Cytocure Medicare operates one associated brand: SSO Hospital. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Health systems are operated by SSO Hospital in Mumbai. | ssohospitals.com |
Business activity
The main business activity of Cytocure Medicare is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Cytocure Medicare Private Limited, buy the company report.
Financials of Cytocure Medicare Private Limited
FY 2024 filings availableCytocure Medicare Private Limited reported revenue of ₹55.94 Cr (up 11% YoY) for FY 2025.
Revenue · FY 2025
₹55.94 Cr ▲ 11%
Net loss · FY 2025
₹2.65 Cr margin -4.7%
EBITDA · FY 2025
₹2.13 Cr margin 3.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 46%
5 years · compounded
▲ 310%
EBITDA CAGR growth
1 year
▼ 65%
3 years · compounded
▼ 21%
5 years · compounded
▲ 98%
Revenue has grown at a compounded annual rate (CAGR) of 310% over five years, including 11% growth in the latest year. EBITDA fell 65% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.13 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.65 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.8% | ||||
| Net Profit Margin | -4.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cytocure Medicare Private Limited, buy the company report.
Board of directors of Cytocure Medicare Private Limited
Cytocure Medicare has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanket Sharad Mehta Also directs: Vatsalya Healthcare LLP, Pred Healthcare Solutions LLP, Specialty Surgical Oncology LLP and 2 more | Director | 07 Jan 2019 | 7 Years 9 Months | Current |
| Jageshwar Prasad Pandey Also directs: Pred Healthcare Solutions LLP, Specialty Surgical Oncology LLP | Director | 07 Jan 2019 | 7 Years 9 Months | Current |
Auditor
Cytocure Medicare Private Limited is audited by AC JHAVERI & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AC JHAVERI & ASSOCIATES | FY 2022 | 137685W |
Shareholding
The shareholding of Cytocure Medicare Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cytocure Medicare Private Limited, buy the company report.
Charges & borrowings
Open charges
₹12.96 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 May 2025 | 101103673 | Hdfc Bank Limited | ₹4.5 Cr | Open | |
| 07 Mar 2025 | 101091231 | Others | ₹12.26 Lakh | Open | |
| 29 Nov 2023 | 100825235 | Others | ₹2.76 Cr | Open | |
| 28 Dec 2022 | 100668097 | Others | ₹32.2 Lakh | Open | |
| 30 Sep 2021 | 100492517 | Others | ₹2 Cr | Open |
To see the full charge records of Cytocure Medicare Private Limited, buy the company report.
Total charge records: 8 View all charges
Legal cases
No court or tribunal cases involving Cytocure Medicare Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cytocure Medicare Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Cytocure Medicare Private Limited has a workforce of 28 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
Employee count
28
Active EPFO establishments
1
Employee growth
86.67%
GST
Cytocure Medicare has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCC9435D1ZM | Maharashtra | Active | 18 Sep 2019 |
To see the full GST registrations and return filing status of Cytocure Medicare Private Limited, buy the company report.
Recent activity
Cytocure Medicare Private Limited has 7 board changes on record since 2019: 6 appointments and 1 cessation. The latest: Nilesh Sureshchandra Chordiya was appointed as Additional Director on 17 Nov 2022.
Charges
A charge with Hdfc Bank Limited of Rs. 4.50 Cr registered on 14 May 2025 with Charge ID 101103673 was modified on 15 May 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 4.50 Cr with Charge ID 101103673 was registered on 14 May 2025.
Charges
A charge with Others amounted to Rs. 0.12 Cr with Charge ID 101091231 was registered on 07 Mar 2025.
Charges
A charge with Others of Rs. 2.76 Cr registered on 29 Nov 2023 with Charge ID 100825235 was modified on 09 Jan 2025.
AGM
Cytocure Medicare Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Cytocure Medicare Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Others amounted to Rs. 2.76 Cr with Charge ID 100825235 was registered on 29 Nov 2023.
Charges
A charge with Others of Rs. 2.05 Cr registered on 16 Dec 2020 with Charge ID 100402236 was modified on 24 Apr 2023.
Charges
A charge with Others amounted to Rs. 0.32 Cr with Charge ID 100668097 was registered on 28 Dec 2022.
Appointed
Nilesh Sureshchandra Chordiya was appointed as Additional Director.
Charges
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 100492517 was registered on 30 Sep 2021.
Charges
A charge with Yes Bank Limited amounted to Rs. 0.34 Cr with Charge ID 100448555 was registered on 29 May 2021.
9 earlier events are in the company report.
Frequently asked questions
Cytocure Medicare is an active private limited company based in Mumbai, Maharashtra, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 07 January 2019 (7+ years old) and is registered under CIN U85300MH2019PTC319108.
Cytocure Medicare has 2 current directors:
- Sanket Sharad Mehta - Director
- Jageshwar Prasad Pandey - Director
The latest financial statements of Cytocure Medicare on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Cytocure Medicare is 27AAHCC9435D1ZM, registered in Maharashtra.
The CIN (Corporate Identification Number) of Cytocure Medicare is U85300MH2019PTC319108. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cytocure Medicare was incorporated on 07 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
Nilesh Sureshchandra Chordiya was appointed as Additional Director on 17 Nov 2022. Chetan Anchan ceased to be Additional Director on 31 Dec 2020. Chetan Anchan was appointed as Director on 17 Mar 2020. Cytocure Medicare has 7 board changes on record in total.
Yes, Cytocure Medicare is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0013613).
The registered office of Cytocure Medicare is at 6th Floor 601 & 602 Plot No.501 F3 Silver Point Lbs Marg New Maneklal Estate Ghatkopar, West, Mumbai, Maharashtra, India – 400086.
Cytocure Medicare operates in the healthcare industry, in the preventive health services segment.